NASDAQ:EVFM
Evofem Biosciences Stock Company Profile
$0.0154
+0.0013 (+9.22%)
At Close: Apr 19, 2024
Information
12400 High Bluff Drive, Suite 600
San Diego CA 92130
858 550 1900
www.evofem.com
Industry: Biotechnology
Sector: Healthcare
Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.
